| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 237.49M | 221.50M | 220.62M | 182.47M | 152.31M | 176.07M |
| Gross Profit | 189.35M | 199.23M | 198.97M | 119.13M | 98.29M | 126.14M |
| EBITDA | 60.70M | 56.02M | 61.46M | 35.56M | 11.95M | 27.42M |
| Net Income | 12.27M | -9.21M | 5.03M | -5.59M | -22.79M | -1.41M |
Balance Sheet | ||||||
| Total Assets | 422.45M | 393.43M | 397.08M | 428.19M | 421.66M | 405.45M |
| Cash, Cash Equivalents and Short-Term Investments | 57.76M | 39.97M | 38.03M | 29.59M | 46.85M | 70.86M |
| Total Debt | 41.62M | 5.02M | 11.16M | 11.12M | 13.65M | 11.36M |
| Total Liabilities | 119.84M | 102.63M | 110.85M | 157.34M | 152.59M | 124.38M |
| Stockholders Equity | 302.60M | 290.80M | 286.69M | 270.84M | 269.07M | 281.07M |
Cash Flow | ||||||
| Free Cash Flow | 51.14M | 25.27M | 49.60M | -5.97M | -14.63M | -24.51M |
| Operating Cash Flow | 53.47M | 26.85M | 50.34M | 32.56M | 30.12M | 10.80M |
| Investing Cash Flow | -21.64M | -22.84M | -38.45M | -45.42M | -51.61M | -35.31M |
| Financing Cash Flow | -3.69M | -3.57M | -3.45M | -4.29M | -2.73M | 58.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$941.43M | 11.05 | 42.94% | 10.16% | 25.67% | 744.90% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | AU$423.90M | 34.06 | 10.18% | 0.43% | 17.12% | 311.38% | |
56 Neutral | AU$510.50M | 13.57 | -3.19% | ― | 0.40% | -280.65% | |
55 Neutral | AU$851.73M | 64.66 | -1.11% | ― | ― | ― |
Nuix director Robert Mactier has increased his holding in the company, purchasing 75,000 ordinary shares in an on-market trade on 5 March 2026 for $139,113.66. Following this transaction, his total interest rose to 300,000 shares, comprising 125,000 held directly and 175,000 held indirectly through a superannuation fund structure.
The change in Mactier’s position, disclosed under ASX requirements, signals additional personal financial commitment from a board member and marginally boosts director-aligned ownership in the company. No related changes in contracts or trades during a closed period were reported, suggesting this was a straightforward on-market share acquisition rather than part of a broader corporate action.
The most recent analyst rating on (AU:NXL) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Limited has appointed Edward Pretty as a director effective 1 March 2026, in a move that updates the company’s board composition and is formally disclosed to the ASX under its listing rules. The initial director’s interest notice confirms that Pretty holds no relevant interests in Nuix securities or related contracts at the time of his appointment, indicating he joins the board without existing equity ties to the company.
The most recent analyst rating on (AU:NXL) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Ltd. has appointed Rachel Barger as a director effective 1 March 2026, expanding the composition of its board. The company disclosed that, at the time of her appointment, Barger does not hold any Nuix securities directly, indirectly, or through related contracts, indicating she joins the board without an existing equity stake.
The filing underscores a straightforward governance update, with no associated share issuances, option grants, or contractual equity interests tied to the new director at this stage. For stakeholders, the notice signals a board refresh focused on governance and oversight rather than an immediate change in capital structure or insider ownership dynamics.
The most recent analyst rating on (AU:NXL) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Ltd. has notified the market that 50,960 NXLAC performance rights have lapsed after the conditions attached to these rights were not met or became incapable of being satisfied. The cessation of these securities slightly reduces the company’s pool of potential equity issuance under its performance rights program, marginally impacting future dilution for existing shareholders but not altering its current issued share capital.
The announcement, filed as an Appendix 3H with the ASX, formally records the cessation date of 27 February 2026 for these performance rights. This disclosure provides transparency around Nuix’s equity incentive arrangements and ensures investors have up-to-date information on changes to its capital management structure, though it does not indicate any operational or strategic shift by the company.
The most recent analyst rating on (AU:NXL) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Ltd. has notified the market of the issuance of 85,609 new fully paid ordinary shares following the conversion of previously unquoted options or other convertible securities. The shares, which were issued on 25 February 2026, reflect the exercise of employee or investor incentives and will modestly increase the company’s share capital and free float, slightly diluting existing holders while signaling continued participation in its equity-based reward structures.
The most recent analyst rating on (AU:NXL) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Citigroup Global Markets Australia and related Citi entities have ceased to be substantial shareholders in Nuix Ltd., after reducing their combined relevant interests in the company’s ordinary fully paid shares. The change, effective 20 February 2026, reflects decreased holdings arising from securities lending arrangements and normal-course stock market transactions.
The move removes Citi from Nuix’s register of substantial holders, potentially altering the company’s institutional investor mix and free float dynamics. While no strategic rationale was disclosed, the reduction in exposure by a major global financial institution may be monitored by the market for implications on liquidity, trading activity and broader sentiment toward the stock.
The most recent analyst rating on (AU:NXL) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix has strengthened its board with the appointment of Rachel Barger and Ted Pretty as additional non-executive directors, effective 1 March 2026, as part of its plan to broaden skills, capability and geographic reach at board level. Barger, a U.S.-based technology and go-to-market leader with experience at UKG, Cisco and SAP, is expected to bolster Nuix’s commercial execution and customer-focused growth in global enterprise software markets.
Pretty, who joins as Macquarie Capital’s nominee director, brings deep experience in technology transformation, strategy, capital markets and governance, including roles at Firmus and Dubber Limited, and will serve on the Nomination & Remuneration Committee. Following these appointments, Nuix’s board will expand to seven non-executive directors, six of whom are independent, underscoring both Macquarie Capital’s ongoing support and the company’s focus on scaling Nuix Neo and sharpening its international market positioning.
The most recent analyst rating on (AU:NXL) stock is a Sell with a A$1.50 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix reported a solid first-half performance for the six months to 31 December 2025, underscored by 8.4% year-on-year growth in annualised contract value to $234.4 million and a 15.2% rise in revenue to $121.2 million. The company highlighted strong demand for its new Nuix Neo platform, which grew ACV 148% to $46.8 million and now accounts for one-fifth of total ACV.
Profitability and cash generation improved markedly, with adjusted management EBITDA up 42.6% to $19.1 million, statutory EBITDA up 72.7% and statutory NPAT swinging to an $11.1 million profit from a prior loss. Underlying cash flow more than quadrupled to $28.4 million, lifting the cash balance to $57.8 million, while Nuix launched a structured Neo migration program and flagged AI-integrated Neo capabilities as a structural competitive advantage, maintaining its full-year ACV guidance range of $240 million to $260 million.
The most recent analyst rating on (AU:NXL) stock is a Sell with a A$1.50 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Limited has applied to the Australian Securities Exchange for quotation of 100,000 ordinary fully paid shares under its employee incentive scheme, to be issued and quoted on 6 February 2026. The modest issuance, which will trade under the existing NXL ticker, reflects ongoing use of equity-based compensation but is unlikely to materially affect the company’s capital structure, instead incrementally broadening its free float and aligning staff interests with shareholders.
The most recent analyst rating on (AU:NXL) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix has scheduled the release of its half-year 2026 financial results for Monday, 23 February 2026, with interim CEO John Ruthven and CFO Peter McClelland to present the numbers via a live webcast at 9:30am AEDT. A replay of the briefing will be made available on the company’s investor website, underscoring Nuix’s ongoing efforts to maintain transparency and engagement with shareholders as it updates the market on its financial and operational performance.
The most recent analyst rating on (AU:NXL) stock is a Buy with a A$3.10 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Limited has notified the market that 142,349 fully paid ordinary shares (ASX code: NXL) were issued on 31 December 2025 following the exercise or conversion of previously unquoted options or other unquoted convertible securities. The issuance, disclosed in an Appendix 3G filing, modestly increases the company’s ordinary share base and reflects the conversion of incentive or other unquoted instruments into listed equity, which may slightly dilute existing shareholders but also signals the realization of value from prior equity-based arrangements.
The most recent analyst rating on (AU:NXL) stock is a Buy with a A$3.10 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Limited has notified the market of the planned issue of 1,357,801 unquoted performance rights under its employee incentive scheme, with an issue date of 14 November 2025. The new unquoted securities, which are subject to transfer restrictions and will not be quoted on the ASX until those restrictions lapse, underline the company’s ongoing use of equity-based remuneration to align staff incentives with shareholder interests and support talent retention within a competitive technology and analytics sector.
The most recent analyst rating on (AU:NXL) stock is a Buy with a A$3.10 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.
Nuix Limited has notified the Australian Securities Exchange of changes to its issued capital, confirming that a tranche of 609,438 performance rights, trading under the code NXLAC, has ceased. The securities lapsed on 31 December 2025 because the conditions attached to these performance rights were not met or could no longer be satisfied, signalling an adjustment to the company’s incentive-based equity structure that may modestly reduce potential future share dilution for existing shareholders.
The most recent analyst rating on (AU:NXL) stock is a Buy with a A$3.10 price target. To see the full list of analyst forecasts on Nuix Ltd. stock, see the AU:NXL Stock Forecast page.